biogen and eisai report successful test on alzheimer's treatment
Published 1 year ago • 1.7K plays • Length 1:07Download video MP4
Download video MP3
Similar videos
-
3:54
eisai ceo on alzheimer's treatment drug trial results
-
1:31
alzheimer's drug decision day: fda to decide on biogen and eisai treatments
-
2:54
biogen and eisai to reveal results of alzheimer's drug trial
-
5:57
cnbc exclusive: eisai u.s. ceo on alzheimer's drug approval
-
1:53
fda approves biogen alzheimer's drug, first new therapy for the disease in nearly two decades
-
7:37
sell-off in big tech is a 'psychological rotation', says neuberger berman's steve eisman
-
26:38
neurosurgeon pioneers alzheimer's, addiction treatments using ultrasound | 60 minutes
-
3:01
biogen's alzheimer's drug is the biggest growth catalyst for the stock, says jefferies' yee
-
3:20
biogen alzheimer's drug shows positive results
-
5:17
biogen ceo: alzheimer's drug shows positive results
-
4:37
biogen alzheimer's drug could get medicare coverage in 2025 if approved, says dr. scott gottlieb
-
4:21
biogen soars on promising results from alzheimer's drug trial
-
1:07
fda approves biogen's alzheimer's drug
-
5:04
what biogen halted its alzheimer's drug trial means for biotech investors
-
3:45
cramer: biogen's alzheimer's treatment would be 'the biggest drug ever'
-
3:01
potential breakthrough: new treatment for alzheimer's
-
1:21
biogen shares drop despite positive alzheimer's drug results
-
3:00
biogen shares drop as big clinics say they won't administer controversial alzheimer's drug
-
16:02
what’s the controversy behind biogen’s alzheimer’s drug?
-
5:19
analyst: it's unclear whether biogen's new alzheimer's drug will get approved
-
5:04
this analyst breaks down the bull case for biogen's alzheimer's drug
-
2:56
biogen shares spike after fda approves alzheimer's drug